AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Canopus Biopharma, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
455.07K
AVG Volume
5.71M
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD)
-800K-600K-400K-200K021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q2-203.95K
23 Q1-782.67K
22 Q4-3.72K
22 Q3-425.23K
22 Q2-3.64K
22 Q1-7K
21 Q4-1.75K
21 Q3-1.75K
Operating Income (USD)
-800K-600K-400K-200K021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q2-190.46K
23 Q1-782.55K
22 Q4-3.72K
22 Q3-425.08K
22 Q2-3.64K
22 Q1-7K
21 Q4-1.76K
21 Q3-1.76K
EBITDA (USD)
-800K-600K-400K-200K021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q2-190.46K
23 Q1-782.55K
22 Q4-3.72K
22 Q3-425.08K
22 Q2-3.64K
22 Q1-7K
21 Q4-1.76K
21 Q3-1.76K
Cash Flows (USD)
-200K-150K-100K-50K050K21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q2-157.02K
23 Q1-1.04K
22 Q4-1.04K
22 Q3-80
22 Q2-3.19K
22 Q1678
21 Q4678
21 Q3-1.75K
EPS (USD)
-0.01-0.01-0-0021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA EPS (USD) by quarter
PeriodEPS (USD)
23 Q2-0
23 Q1-0.01
22 Q4-0
22 Q3-0
22 Q2-0
22 Q1-0
21 Q4-0
21 Q3-0
Expenses (USD)
0200K400K600K800K21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q2190.46K
23 Q1782.55K
22 Q43.72K
22 Q3425.08K
22 Q23.64K
22 Q17K
21 Q41.75K
21 Q31.75K
Cash & Debt (USD)
050K100K150K200KCashShort Term Debt21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q26.15K
23 Q13.17K
22 Q44.21K
22 Q37.81K
22 Q27.89K
22 Q11.13K
21 Q41.13K
21 Q30
Debt ratios
-0.15-0.1-0.05-022 Q222 Q322 Q423 Q123 Q2
CBIA Debt ratios by quarter
PeriodDebt ratios
23 Q2-0.13
23 Q1-0.01
22 Q4-0.01
22 Q3-0.01
22 Q2-0.15
Return on Capital
-2000%0%2000%4000%6000%21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Return on Capital by quarter
PeriodReturn on Capital
23 Q2110.27%
23 Q15417.93%
22 Q427.99%
22 Q34446.11%
22 Q239%
22 Q1114.76%
21 Q428.78%
21 Q3-195%
Shares Outstanding
050M100M150M21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Shares Outstanding by quarter
PeriodShares Outstanding
23 Q2139.9M
23 Q1126.45M
22 Q4122.1M
22 Q3123.73M
22 Q2107.16M
22 Q1102.7M
21 Q498.24M
21 Q398.24M
Book Value Per Share (USD)
-0-0-00021 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q2-0
23 Q1-0
22 Q4-0
22 Q3-0
22 Q2-0
22 Q1-0
21 Q4-0
21 Q30
Total Assets (USD)
02K4K6K8K21 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
CBIA Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q26.15K
23 Q13.17K
22 Q44.21K
22 Q37.81K
22 Q27.89K
22 Q11.13K
21 Q41.13K
21 Q3900
Free Cash Flow Yield
-150000%-100000%-50000%0%med -1137.84%Jan 25May 25Sep 25Jan 26May 26Sep 26
CBIA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1137.84%
Sep 26-1137.84%
Aug 26-1137.84%
Aug 26-1137.84%
Aug 26-1137.84%
Aug 26-1137.84%
Jul 26-1137.84%
Jul 26-1137.84%
Jul 26-1137.84%
Jul 26-1137.84%
Jul 26-1137.84%
Jun 26-1137.84%
Jun 26-1137.84%
Jun 26-113784.01%
Jun 26-1137.84%
May 26-1137.84%
May 26-113784.01%
May 26-1137.84%
May 26-113784.01%
May 26-113784.01%
Apr 26-113784.01%
Apr 26-1137.84%
Apr 26-1137.84%
Apr 26-1137.84%
Mar 26-113784.01%
Mar 26-1137.84%
Mar 26-113784.01%
Mar 26-1137.84%
Feb 26-1137.84%
Feb 26-113784.01%
Feb 26-113784.01%
Feb 26-1137.84%
Jan 26-1137.84%
Jan 26-1137.84%
Jan 26-1137.84%
Jan 26-113784.01%
Jan 26-1137.84%
Dec 25-113784.01%
Dec 25-1137.84%
Dec 25-1137.84%
Dec 25-1137.84%
Nov 25-113784.01%
Nov 25-1137.84%
Nov 25-1137.84%
Nov 25-1137.84%
Oct 25-1137.84%
Oct 25-1137.84%
Oct 25-1137.84%
Oct 25-1137.84%
Oct 25-113784.01%
Sep 25-1137.84%
Sep 25-113784.01%
Sep 25-1137.84%
Sep 25-1137.84%
Aug 25-1137.84%
Aug 25-1137.84%
Aug 25-1137.84%
Aug 25-1137.84%
Aug 25-1137.84%
Jul 25-11378.4%
Jul 25-1137.84%
Jul 25-1137.84%
Jul 25-1137.84%
Jun 25-1137.84%
Jun 25-1137.84%
Jun 25-1137.84%
Jun 25-1137.84%
May 25-1137.84%
May 25-1137.84%
May 25-1137.84%
May 25-1137.84%
May 25-1137.84%
Apr 25-1137.84%
Apr 25-1137.84%
Apr 25-1137.84%
Apr 25-1137.84%
Mar 25-1137.84%
Mar 25-1137.84%
Mar 25-1137.84%
Mar 25-1137.84%
Feb 25-1137.84%
Feb 25-1137.84%
Feb 25-1137.84%
Feb 25-1137.84%
Jan 25-1137.84%
Jan 25-1137.84%
Jan 25-1137.84%
Jan 25-1137.84%
Jan 25-568.92%
Dec 24-1137.84%
Dec 24-1137.84%
Dec 24-758.56%
Dec 24-1137.84%
Nov 24-1137.84%
Nov 24-568.92%
Nov 24-1137.84%
Nov 24-1137.84%
Nov 24-568.92%
Oct 24-1137.84%
Oct 24-758.56%
Price to Book
050001000015000med 7641.09Dec 21Dec 21Dec 21Jan 22Jan 22Feb 22Feb 22
CBIA Price to Book by quarter
PeriodPrice to Book
Feb 224366.34
Feb 227641.09
Feb 224366.34
Feb 224366.34
Jan 223274.75
Jan 227641.09
Jan 227641.09
Jan 2214485.32
Dec 2114190.59
Dec 2114190.59
Dec 2110915.84
Dec 2110915.84
Dec 2110915.84
Canopus Biopharma, Inc.
CBIA
Stockpicker

Video analysis: CBIA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.